⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL28198119 | 0.75 | — | — | |
| SCHEMBL28043554 | 0.72 | — | — | |
| Acetic Acid SCHEMBL28885080 | 0.72 | FFAR3 (0.50) | — | |
| Acetic Acid SCHEMBL29111161 | 0.72 | FFAR3 (0.50) | — | |
| Acetic Acid SCHEMBL29117018 | 0.72 | FFAR3 (0.50) | — | |
| Acetic Acid SCHEMBL28368105 | 0.72 | FFAR3 (0.50) | — | |
| Acetic Acid SCHEMBL29130683 | 0.72 | FFAR3 (0.50) | — | |
| Acetic Acid SCHEMBL28816529 | 0.72 | FFAR3 (0.50) | — | |
| Acetic Acid SCHEMBL27903012 | 0.72 | FFAR3 (0.50) | — | |
| SCHEMBL8432459 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111961089-B | Organometallic complex and preparation method and application thereof | 南京佳诺霖光电科技有限公司 | 2023-10-31 | — | — | CN | disclosed |
| US-20230265080-A1 | MODULATORS OF ALPHA-1 ANTITRYPSIN | VERTEX PHARMA (US) | 2023-08-24 | — | — | US | disclosed |
| CN-116531281-A | Rose moisturizing repair liquid and preparation method thereof | 四川好医生中藏药业有限公司 | 2023-08-04 | — | — | CN | disclosed |
| EP-3571210-B1 | OXO-NITROGENATED IRON COMPLEX, CATALYTIC SYSTEM COMPRISING SAID OXO-NITROGENATED IRON COMPLEX AND PROCESS FOR THE (CO)POLYMERIZATION OF CONJUGATED DIENES | VERSALIS SPA (IT) | 2022-04-13 | — | — | EP | disclosed |
| CN-105153235-B | Phosphor material | 通用显示公司 | 2019-05-10 | — | — | CN | disclosed |
| CN-108463517-A | Including the non-aqueous inks composition of transition metal complex and its purposes in organic electronics | 日产化学工业株式会社 | 2018-08-28 | — | — | CN | disclosed |
| US-20170174690-A1 | SUBSTITUTED 4,5,6,7-TETRAHYDRO-PYRAZOLO[1,5-a]PYRAZINE DERIVATIVES AND 5,6,7,8-TETRAHYDRO-4H-PYRAZOLO[1,5-a][1,4]DIAZEPINE DERIVATIVES AS ROS1 INHIBITORS | JANSSEN PHARMACEUTICA NV (BE) | 2017-06-22 | — | — | US | disclosed |
| CN-105153235-A | Phosphorescent materials | UNIVERSAL DISPLAY CORP | 2015-12-16 | — | — | CN | disclosed |
| CN-103087109-B | Phosphor material | UNIVERSAL DISPLAY CORP. (US) | 2015-10-28 | — | — | CN | disclosed |
| CN-103339137-A | A metal complex comprising a ligand having a combination of donor-acceptor substituents | SOLVAY | 2013-10-02 | — | — | CN | disclosed |
| US-20090036353-A1 | Insulin Derivatives Conjugated with Structurally Well Defined Branched Polymers | NOVO NORDISK A/S (DK) | 2009-02-05 | — | — | US | disclosed |
| US-20090030046-A1 | NOVEL GLUCOKINASE ACTIVATORS AND METHODS OF USING SAME | BRISTOL-MYERS SQUIBB COMPANY | 2009-01-29 | — | — | US | disclosed |
| EP-1991703-A2 | A METHOD FOR NONINVASIVELY AND QUANTITATIVELY MONITORING THERAPEUTIC AND DIAGNOSTIC TRANSGENE EXPRESSION INDUCED BY EX VIVO AND IN VIVO GENE TARGETING IN ORGANS, TISSUES AND CELLS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2008-11-19 | — | — | EP | disclosed |
| EP-1661568-B1 | Compounds effecting Glucokinase | ASTRAZENECA AB (SE) | 2008-09-03 | — | — | EP | disclosed |
| US-20080125436-A1 | 4-(5-{(1R)-1-[5-(3-Chlorophenyl)isoxazol-3-yl]ethoxy}-4-methyl-4H-1,2,- 4-triazol-3-yl)-1-methylpyridin-2(1H)-one; transient lower esophageal sphincter relaxations; gastroesophageal reflux disease; pain; anxiety; irritable bowel syndrome; metabotropic glutamate receptor inhibitors; peripherally acting | ASTRAZENECA AB (SE) | 2008-05-29 | — | — | US | disclosed |
| US-20070249056-A1 | Peptide and Protein Fragmentation by Lysine Residue Originated Reactions | VANDERBILT UNIVERSITY | 2007-10-25 | — | — | US | disclosed |
| WO-2007109335-A2 | A METHOD FOR NONINVASIVELY AND QUANTITATIVELY MONITORING THERAPEUTIC AND DIAGNOSTIC TRANSGENE EXPRESSION INDUCED BY EX VIVO AND IN VIVO GENE TARGETING IN ORGANS, TISSUES AND CELLS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2007-09-27 | — | — | WO | disclosed |
| WO-2007026024-A2 | BENZODIAZEPINES AS HCV INHIBITORS | TIBOTEC PHARMACEUTICALS LTD. (IE) | 2007-03-08 | — | — | WO | disclosed |
| CN-1616471-A | Organometallic complex and organic electroluminescent device including the same | YOUDA PHOTOELECTRIC CO LTD (CN) | 2005-05-18 | — | — | CN | disclosed |
| CN-1352681-A | Enzymatic reductions with dihydrogen via metal catalyzed cofactor regeneration | EASTMAN CHEM CO (US) | 2002-06-05 | — | — | CN | disclosed |